Literature DB >> 2542032

Antibody reactivity to cytomegalovirus structural polypeptides in subclinical and clinical human immunodeficiency virus infections.

M P Landini1, G Mirolo, M C Re, A Ripalti, M La Placa.   

Abstract

A total of 56 sera from asymptomatic HIV-seropositive subjects and patients with symptomatic HIV infection were studied by immunoblotting for IgM, IgG and IgG subclass reactivity against cytomegalovirus structural polypeptides. The results showed a high percentage of IgM-positive sera in the asymptomatic patients, and IgM reactivity was particularly high against a polypeptide of intermediate molecular weight (p66). IgG reactivity was very high against the majority of viral structural polypeptides with the possible exceptions of p82 and p61, in all patients. Antibody to these polypeptides decreased with the increase in HIV-specific symptoms. No significant difference in the reactivity of IgG subclass to viral polypeptides was found among the different groups of subjects, except for a generalized increase in IgG subclass reactivity from asymptomatic to HIV-specific symptomatic patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542032     DOI: 10.1007/bf01963904

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

Review 1.  Human cytomegalovirus proteins.

Authors:  M P Landini; S Michelson
Journal:  Prog Med Virol       Date:  1988

2.  Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.

Authors:  V A Sundqvist; A Linde; R Kurth; A Werner; E B Helm; M Popovic; R C Gallo; B Wahren
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

3.  Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection.

Authors:  M P Landini; G Mirolo; P Coppolecchia; M C Re; M La Placa
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

4.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

5.  Analysis by immunoblotting of human cytomegalovirus antibody in sera of renal transplant recipient.

Authors:  K Shimokawa; T Murayama; S Ishida; T Furukawa
Journal:  J Med Virol       Date:  1987-04       Impact factor: 2.327

6.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.

Authors:  M P Landini; M C Re; G Mirolo; B Baldassarri; M La Placa
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

7.  Herpesvirus infections in the acquired immune deficiency syndrome.

Authors:  G V Quinnan; H Masur; A H Rook; G Armstrong; W R Frederick; J Epstein; J F Manischewitz; A M Macher; L Jackson; J Ames
Journal:  JAMA       Date:  1984-07-06       Impact factor: 56.272

8.  Application of denatured, electrophoretically separated, and immobilized lysates of herpes simplex virus-infected cells for detection of monoclonal antibodies and for studies of the properties of viral proteins.

Authors:  D K Braun; L Pereira; B Norrild; B Roizman
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

9.  Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus.

Authors:  L E Rasmussen; R M Nelson; D C Kelsall; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  Reactivity of cytomegalovirus structural polypeptides with different subclasses of IgG present in human serum.

Authors:  M P Landini; B Baldassarri; G Mirolo; A Ripalti; M La Placa
Journal:  J Infect       Date:  1988-03       Impact factor: 6.072

View more
  2 in total

1.  Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals.

Authors:  P J Converse; T E Fehniger; A Ehrnst; O Strannegård; S Britton
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirus.

Authors:  S Spaderna; H Blessing; E Bogner; W Britt; M Mach
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.